Implement a change to bioburden test methods.
| Device | ProCol Vascular Bioprosthesis | 
| Classification Name | Tissue Graft Of 6mm And Greater | 
| Generic Name | Tissue Graft Of 6mm And Greater | 
| Applicant | LEMAITRE VASCULAR INC | 
| Date Received | 2018-08-20 | 
| Decision Date | 2018-09-19 | 
| PMA | P020049 | 
| Supplement | S007 | 
| Product Code | LXA | 
| Docket Number | Premarket Approval (PMA) // Quick Links: Skip To Main Page Content Skip To Search Skip To Topics Menu Skip To Common Links U.S. Food & Drug Administration   Follow FDA En Español Search FDA   Home Food Drugs Medical Devices Radia | 
| Advisory Committee | Cardiovascular | 
| Supplement Type | 30-day Notice | 
| Supplement Reason | Process Change - Manufacturer/sterilizer/packager/supplier | 
| Expedited Review | No | 
| Combination Product | No | 
| Applicant Address | LEMAITRE VASCULAR INC 63 Second Avenue burlington, MA 01803 | 
Supplemental Filings
| Supplement Number | Date | Supplement Type | 
|---|
| P020049 |  | Original Filing | 
			        | S007 | 2018-08-20 | 30-day Notice | 
			        | S006 | 2018-06-29 | Normal 180 Day Track No User Fee | 
			        | S005 | 2017-12-08 | Normal 180 Day Track No User Fee | 
			        | S004 | 2014-10-01 | 30-day Notice | 
			        | S003 | 2014-07-11 | Normal 180 Day Track No User Fee | 
			        | S002 | 2010-02-22 | 30-day Notice | 
			        | S001 | 2009-09-17 | 30-day Notice | 
NIH GUDID Devices